readthroughSign in
CompanyBCYCNasdaqCambridge, X0

Bicycle Therapeutics Plc

Bicycle Therapeutics develops Bicycle molecules, synthetic constrained peptides for drug conjugates targeting cancer antigens.

SCHEDULE 13G/ANov 16Latest SEC filing
Oct 29Latest story